Phase II Study of Continuous Venous Infusion of 5-Fluorouracil in Advanced Pancreatic Cancer
作者:
Hisao Tajiri,
Masayoshi Yoshimori,
Nobuo Okazaki,
Makoto Miyaji,
期刊:
Oncology
(Karger Available online 1991)
卷期:
Volume 48,
issue 1
页码: 18-21
ISSN:0030-2414
年代: 1991
DOI:10.1159/000226887
出版商: S. Karger AG
关键词: Pancreatic cancer;Continuous venous infusion;5-Fluorouracil
数据来源: Karger
摘要:
Continuous venous infusion of 5-fluorouracil (5FU) was investigated in 18 patients with measurable advanced cancer of the pancreas. 5FU was given for 7 days in a dose of 500 mg/m2 by continuous venous infusion over a 24-hour period and then followed by a dose of 170 mg/m2 for more than 28 days. Ten patients had no change including 1 patient with minor response, and 4 patients had disease progression. Serum CA19-9 levels were measured serially after chemotherapy in 13 of 14 evaluable patients. In 3 of 10 patients who showed high levels before treatment, serum CA19-9 levels were significantly decreasing after treatment.
点击下载:
PDF
(1400KB)
返 回